MA42973A - MANUFACTURE AND USE OF PERSONALIZED HYPERIMMUNITY UF IN THE TREATMENT OF PSORIASIS - Google Patents

MANUFACTURE AND USE OF PERSONALIZED HYPERIMMUNITY UF IN THE TREATMENT OF PSORIASIS

Info

Publication number
MA42973A
MA42973A MA042973A MA42973A MA42973A MA 42973 A MA42973 A MA 42973A MA 042973 A MA042973 A MA 042973A MA 42973 A MA42973 A MA 42973A MA 42973 A MA42973 A MA 42973A
Authority
MA
Morocco
Prior art keywords
hyperimmunity
personalized
psoriasis
manufacture
treatment
Prior art date
Application number
MA042973A
Other languages
French (fr)
Inventor
Chiurciu Constantin
Victor Patrascu Ionel
Iuliana Mihai
Lucica Sima
Chiurciu Viorica
Original Assignee
Romvac Company Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romvac Company Sa filed Critical Romvac Company Sa
Publication of MA42973A publication Critical patent/MA42973A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
MA042973A 2015-10-16 2016-01-08 MANUFACTURE AND USE OF PERSONALIZED HYPERIMMUNITY UF IN THE TREATMENT OF PSORIASIS MA42973A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ROA201500735A RO130965A8 (en) 2015-10-16 2015-10-16 Production and use of customized hyperimmune egg () in psoriasis treatment

Publications (1)

Publication Number Publication Date
MA42973A true MA42973A (en) 2018-08-22

Family

ID=55754390

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042973A MA42973A (en) 2015-10-16 2016-01-08 MANUFACTURE AND USE OF PERSONALIZED HYPERIMMUNITY UF IN THE TREATMENT OF PSORIASIS

Country Status (4)

Country Link
EP (1) EP3362092A1 (en)
MA (1) MA42973A (en)
RO (1) RO130965A8 (en)
WO (1) WO2017065626A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO132299A3 (en) * 2017-06-06 2018-12-28 Fântână Raul Sorin Composition and method for preparing and evaluating a complex immunogen named i-spga meant to produce immunologically active proteins
US11319382B1 (en) 2021-06-28 2022-05-03 King Abdulaziz University Methods for producing and using IgY antibodies targeting the middle east respiratory syndrome coronavirus spike protein to treat or prevent MERS-CoV infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1068524C (en) * 1997-06-23 2001-07-18 叶庆炜 Process for preparing medicine for curing intractable psoriasis
JP2002509109A (en) * 1998-01-19 2002-03-26 ディーシーヴィー インコーポレイテッド Compositions and methods for treating and preventing arthritis and / or autoimmune diseases
BR9915732A (en) * 1998-11-16 2001-09-04 Genway Biotech Inc Antibody generation using polynucleotide vaccination in bird species
NZ575918A (en) * 2006-08-31 2012-03-30 A C N 135 493 391 Pty Ltd As Trustee For Conca Unit Trust Treatment and/or prevention of non-infectious medical conditions using antibody-containing milk or egg products
US20100233162A1 (en) * 2007-08-30 2010-09-16 Bengt Agerup LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS
JP5439127B2 (en) * 2009-11-13 2014-03-12 株式会社さいわいメディカル Treatment for psoriasis or atopic dermatitis
RO129645B1 (en) * 2014-02-25 2022-05-30 Romvac Company S.A. Process for obtaining and using hen immunoglobulins (igy)
RO130213A8 (en) * 2014-10-29 2017-06-30 Romvac Company S.A. Production and use of hyperimmune egg - pc2

Also Published As

Publication number Publication date
RO130965A8 (en) 2017-06-30
RO130965A0 (en) 2016-03-30
WO2017065626A1 (en) 2017-04-20
EP3362092A1 (en) 2018-08-22

Similar Documents

Publication Publication Date Title
MA45192A (en) ASSOCIATION TREATMENT
DK3641819T3 (en) USE OF CANNABIDIOL IN TREATMENT OF TUBEOUS SCLEROSIS COMPLEX
DK3334422T3 (en) USE OF CANNABIDIOLIC ACID IN THE TREATMENT OF EPILEPSY
MA42819A (en) METHODS FOR THE TREATMENT OF ARENAVIRIDAE AND CORONAVIRIDAE VIRAL INFECTIONS
DK3313401T3 (en) NANOPARTICLES INCLUDING SIROLIMUS AND ALBUMIN FOR USE IN THE TREATMENT OF EPITHELIOID CELL TUMORS
MA45481A (en) USE OF EXOSOMES FOR THE TREATMENT OF DISEASES
DK3233130T3 (en) NUCLEIC ACID CONSTRUCTIONS AND GENERATIVE VECTORS FOR USE IN THE TREATMENT OF WILSON DISEASE
MA40008A (en) ANTAGONIST ACTRII FOR THE TREATMENT AND PREVENTION OF SKIN ULCER IN A SUBJECT WITH ANEMIA
MA45073A (en) NEW PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDING FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS
DK3432899T3 (en) USE OF PROBIOTICS IN THE TREATMENT AND / OR PREVENTION OF PSORIASIS
GB201517215D0 (en) Use of cannabinoids in the treatment of inflammatory skin diseases
DK3882250T3 (en) TETRAHYDROPYRANYL-AMINO-PYRROLOPYRIMIDINONE FOR USE IN THE TREATMENT OF BTK-MEDIATED DISORDERS
DK3442513T3 (en) USE OF CANNABIDIOLIC ACID IN THE TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED DISORDERS
MA47450A (en) SULFINYLPYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER
DK2945642T3 (en) FACTOR 1 PROTEIN FOR USE IN THE TREATMENT OR PREVENTION OF DISEASE
DK3391902T3 (en) PLASMINOGEN FOR USE IN THE TREATMENT OF DIABETIC ANGIOCARDIOPATHY
MA44762A (en) SEMAGLUTIDE USED IN THE TREATMENT OF CARDIOVASCULAR DISEASES
FR3022917B1 (en) ELECTRODE MATERIAL AND ITS USE IN THE MANUFACTURE OF INERT ANODE
MA42915A (en) PYRIDINES AND THEIR USE IN CANCER TREATMENT
MA43361A (en) COMPOSITION FOR THE CARE AND PROTECTION OF CROPS
DK3149049T3 (en) IL-22 FOR USE IN THE TREATMENT OF METABOLISM DISEASES
DK3423060T3 (en) Imatinib for use in the treatment of stroke
DK3386916T3 (en) IMPROVEMENTS IN THE PRODUCTION OF SILICON NANOPARTICLES AND THEIR USES
MA42973A (en) MANUFACTURE AND USE OF PERSONALIZED HYPERIMMUNITY UF IN THE TREATMENT OF PSORIASIS
MA42913A (en) PYRIDAZINONES AND THEIR USE IN THE TREATMENT OF CANCER